The current valuation score of Veracyte Inc is 7.18, ranking 241 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is 49.91, which is 192.92% below the recent high of 146.20 and 744.01% above the recent low of -321.44.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.